Skip to main content
Livermore
Livermore
ZHEN

Corvus Pharmaceuticals, Inc.

CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001626971

No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.

Holders of 5% or more of CRVS

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Corvus Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of CRVS
HolderLatest formStakeChangeFirst filedLatest filingFiling
OrbiMed Advisors LLC13D/A10.30%8.61M shares−1.90 ppfrom 12.20%Feb 17, 20218 filingsJan 27, 2026SEC
Miller Richard A MD13G/A7.80%6.09M shares+0.10 ppfrom 7.70%Feb 16, 20216 filingsFeb 13, 2026SEC
Sirenia Capital Management LP13G7.50%6.83M sharesNewMay 15, 20261 filingMay 15, 2026SEC
BlackRock, Inc.13G/A7.50%6.33M shares+1.10 ppfrom 6.40%Oct 17, 20253 filingsJul 27, 2026SEC
State Street Corp13G5.30%4.47M sharesNewAug 7, 20261 filingAug 7, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

45 Schedule 13D and 13G filings on Corvus Pharmaceuticals, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on CRVS
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 7, 20269:16 AM ETState Street Corp13G5.30%4.47M sharesNewJun 30, 2026SEC
Jul 27, 20264:25 PM ETBlackRock, Inc.13G/A7.50%6.33M shares+1.10 ppfrom 6.40%Jun 30, 2026SEC
May 15, 20264:13 PM ETPoint72 Asset Management, L.P.and 2 others13G/A0.00%0 shares–Below 5%Mar 31, 2026SEC
May 15, 20268:11 AM ETSirenia Capital Management LPand 1 other13G7.50%6.83M sharesNewMar 31, 2026SEC
Apr 27, 20264:12 PM ETBlackRock, Inc.13G/A6.40%5.39M shares+1.00 ppfrom 5.40%Mar 31, 2026SEC
Mar 26, 20265:39 PM ETVanguard Group Inc13G/A0.00%0 shares−5.18 ppfrom 5.18%Below 5%Mar 13, 2026SEC
Feb 13, 20264:31 PM ETMiller Richard A MDand 2 others13G/A7.80%6.09M shares+0.10 ppfrom 7.70%Dec 31, 2025SEC
Feb 5, 202610:29 AM ETAdams Street Partners LLCand 9 others13D/A3.90%3.28M shares–Below 5%Jan 23, 2026SEC
Jan 30, 20261:26 PM ETVanguard Group Inc13G5.18%3.87M sharesNewDec 31, 2025SEC
Jan 27, 20268:38 PM ETOrbiMed Advisors LLCand 1 other13D/A10.30%8.61M shares−1.90 ppfrom 12.20%Jan 23, 2026SEC
Oct 17, 20256:40 PM ETBlackRock, Inc.13G5.40%4.02M sharesNewSep 30, 2025SEC
Aug 14, 20251:32 PM ETSamlyn Capital, LLCand 2 others13G/A0.00%0 shares−6.00 ppfrom 6.00%Below 5%Jun 30, 2025SEC
May 15, 20253:34 PM ETSamlyn Capital, LLCand 2 others13G/A6.00%4.07M shares−3.80 ppfrom 9.80%Mar 31, 2025SEC
May 14, 20258:49 PM ETOrbiMed Advisors LLCand 1 other13D/A12.20%9.79M shares−1.60 ppfrom 13.80%May 12, 2025SEC
May 1, 20259:20 PM ETOrbiMed Advisors LLCand 1 other13D/A13.80%9.79M shares–Apr 29, 2025SEC
Feb 14, 20251:53 PM ETSamlyn Capital, LLCand 2 others13G/A9.80%6.67M shares–Dec 31, 2024SEC
Feb 13, 20254:30 PM ETMiller Richard A MDand 2 others13G/A7.70%5.22M shares–Dec 31, 2024SEC
Aug 1, 2024Samlyn Capital, LLC13G/AOld format–––SEC
May 13, 2024Samlyn Capital, LLC13G/AOld format–––SEC
May 9, 2024Point72 Asset Management, L.P.13GOld format–New–SEC
May 8, 2024OrbiMed Advisors LLC13D/AOld format–––SEC
Feb 14, 2024Samlyn Capital, LLC13GOld format–New–SEC
Feb 13, 2024Miller Richard A MD13G/AOld format–––SEC
Feb 14, 2023Tang Capital Partners LP13G/AOld format–––SEC
Feb 13, 2023CHI Advisors LLC13GOld format–New–SEC
Feb 10, 2023Miller Richard A MD13G/AOld format–––SEC
Jan 30, 2023Integrated Core Strategies (US) LLC13G/AOld format–––SEC
Feb 14, 2022Tang Capital Partners LP13G/AOld format–––SEC
Feb 14, 2022Venrock Healthcare Capital Partners II, L.P.13G/AOld format–––SEC
Feb 14, 2022Miller Richard A MD13G/AOld format–––SEC
Feb 14, 2022Biotechnology Value Fund L P13G/AOld format–––SEC
Jan 18, 2022Integrated Core Strategies (US) LLC13G/AOld format–––SEC
Dec 6, 2021Integrated Core Strategies (US) LLC13GOld format–––SEC
Nov 3, 2021OrbiMed Advisors LLC13D/AOld format–––SEC
Oct 22, 2021Integrated Core Strategies (US) LLC13GOld format–New–SEC
Oct 5, 2021EcoR1 Capital, LLC13G/AOld format–––SEC
Sep 30, 2021Venrock Healthcare Capital Partners II, L.P.13GOld format–New–SEC
Sep 23, 2021EcoR1 Capital, LLC13G/AOld format–––SEC
Sep 22, 2021Tang Capital Partners LP13GOld format–New–SEC
Sep 22, 2021OrbiMed Advisors LLC13D/AOld format–––SEC
Aug 4, 2021OrbiMed Advisors LLC13D/AOld format–––SEC
May 11, 2021EcoR1 Capital, LLC13GOld format–New–SEC
Feb 17, 2021OrbiMed Advisors LLC13D/AOld format–––SEC
Feb 16, 2021Miller Richard A MD13G/AOld format–––SEC
Feb 12, 2021Biotechnology Value Fund L P13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Corvus Pharmaceuticals, Inc. shares.

No Form 144 notices for Corvus Pharmaceuticals, Inc. are on file.